Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors.
Miyata J, Kasahara C, Asano T, Ito S, Seki N, Kato Y, Morikawa N, Nozaki K, Nishimura K, Akamatsu H, Taguchi Y, Yamaguchi T, Abe Y, Ohkubo M, Watanabe T, Ohta M, Takeuchi M.
Miyata J, et al. Among authors: ohkubo m.
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5681-4. doi: 10.1016/j.bmcl.2012.06.087. Epub 2012 Jul 6.
Bioorg Med Chem Lett. 2012.
PMID: 22853997